Latest news
Scientists recently discovered a novel relationship between a shelled amoeba and an unknown flagellate using single-cell transcriptomics
A new study is the first to report a shelled microbial eukaryote housing a flagellated microbial eukaryote. This shows there is much we do not know about the microbial world.
Ebola preparedness needs to move beyond a single virus species
Decades of Ebola preparedness have produced vaccines, diagnostics and treatments, but many were built primarily around Zaire ebolavirus. A new perspective argues that future preparedness should span the wider ebolavirus genus, combining broader diagnostics, multivalent vaccines, conserved therapeutic targets and continuous genomic surveillance.
Regular coffee drinking linked to changes in gut bacteria and intestinal function
If you drink coffee regularly, it appears to alter not only your gut bacteria but also the physiology of the gut itself. That is the conclusion of a study from the University of Copenhagen, which may help point the way towards better treatments for constipation.
Scientists image bacterial poles at molecular resolution for the first time
Researchers have imaged the ends of live rod-shaped bacteria at molecular resolution for the first time. The technique revealed structural differences between species and changes linked to cell division, offering a new way to study bacterial surfaces and potentially uncover weaknesses in drug-resistant pathogens.
NIH awards $57.5m to strengthen emerging infectious disease research
Boston University’s high-containment infectious disease laboratory has received $57.5 million in new federal funding to strengthen research on emerging pathogens. The five-year award will support work on vaccines, diagnostics and treatments for threats including Ebola, Marburg, dengue and other high-risk viruses.
Eels transmit a virus through biting: a discovery that changes our understanding of viral infections in fish
Contrary to what was previously believed, viruses infecting fish are not transmitted exclusively through water acting as an abiotic vector. A team of researchers has demonstrated that a virus affecting European eels can spread very efficiently through biting during aggressive interactions between individuals.
Scientists recently discovered a novel relationship between a shelled amoeba and an unknown flagellate using single-cell transcriptomics
A new study is the first to report a shelled microbial eukaryote housing a flagellated microbial eukaryote. This shows there is much we do not know about the microbial world.
Regular coffee drinking linked to changes in gut bacteria and intestinal function
If you drink coffee regularly, it appears to alter not only your gut bacteria but also the physiology of the gut itself. That is the conclusion of a study from the University of Copenhagen, which may help point the way towards better treatments for constipation.
Scientists image bacterial poles at molecular resolution for the first time
Researchers have imaged the ends of live rod-shaped bacteria at molecular resolution for the first time. The technique revealed structural differences between species and changes linked to cell division, offering a new way to study bacterial surfaces and potentially uncover weaknesses in drug-resistant pathogens.
Perpetual Next signs agreement to accelerate the roll-out of standardized biomethanol plants
Perpetual Next have signed a License and Engineering Agreement with Air Liquide Engineering and Technologies for the supply of syngas-to-methanol technology for Perpetual Next’s first biomethanol facility, with an option to extend across other biomethanol sites.
AFYREN and Terrial renew their partnership for French-manufactured potash fertilizers
AFYREN and Terrial today announce the renewal of their strategic partnership with the signing of a new multi-year fertilizer supply contract, worth several tens of millions of euros This long-term contract strengthens both companies’ commitment to making French agriculture more sustainable and less dependent on international fertilizer markets.
AI tool CLARA accelerates the development of bioreactors
In large-scale industrial bioreactors, the smallest differences in temperature, pH value or oxygen content determine the success or failure of a process. Researchers have now presented the CLARA software toolbox, which can be used to simulate the processes in the reactors 10,000 times faster.
New microscopy technique brings cellular detail into deeper focus
A new microscopy technique resolves structures smaller than 100 nanometers, roughly a thousand times thinner than a human hair, without giving up the ability to image deep into intact samples.
Research helps bring new microbiome-focused women’s health product to market
Research has helped inform the development of BloomCalma™, a new intimate care product designed to support skin comfort during pregnancy and after childbirth. The product is the latest example of how academic research can be translated into commercial products.
Ebola preparedness needs to move beyond a single virus species
Decades of Ebola preparedness have produced vaccines, diagnostics and treatments, but many were built primarily around Zaire ebolavirus. A new perspective argues that future preparedness should span the wider ebolavirus genus, combining broader diagnostics, multivalent vaccines, conserved therapeutic targets and continuous genomic surveillance.
NIH awards $57.5m to strengthen emerging infectious disease research
Boston University’s high-containment infectious disease laboratory has received $57.5 million in new federal funding to strengthen research on emerging pathogens. The five-year award will support work on vaccines, diagnostics and treatments for threats including Ebola, Marburg, dengue and other high-risk viruses.
CARB-X funds UNSW Sydney to develop novel antibiotic targeting drug-resistant Gram negative bacterial infections
Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) is awarding US$853k to UNSW Sydney to support the development of synthetic darobactin analogues, a new class of antibiotic designed to kill multidrug-resistant Gram-negative bacteria.